Pennant (PNTG)
Market Price (12/23/2025): $29.43 | Market Cap: $1.0 BilSector: Health Care | Industry: Health Care Facilities
Pennant (PNTG)
Market Price (12/23/2025): $29.43Market Cap: $1.0 BilSector: Health CareIndustry: Health Care Facilities
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Strong revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is 30% | Trading close to highsDist 52W High is -2.5% | Expensive valuation multiplesP/EBITPrice/EBIT or Price/(Operating Income) ratio is 23x, P/EPrice/Earnings or Price/(Net Income) is 38x |
| Low stock price volatilityVol 12M is 38% | Key risksPNTG key risks include [1] an inability to attract and retain the key local leadership essential to its decentralized operating model. | |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Telehealth Platforms, Show more. |
| Strong revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is 30% |
| Low stock price volatilityVol 12M is 38% |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Telehealth Platforms, Show more. |
| Trading close to highsDist 52W High is -2.5% |
| Expensive valuation multiplesP/EBITPrice/EBIT or Price/(Operating Income) ratio is 23x, P/EPrice/Earnings or Price/(Net Income) is 38x |
| Key risksPNTG key risks include [1] an inability to attract and retain the key local leadership essential to its decentralized operating model. |
Why The Stock Moved
Qualitative Assessment
AI Analysis | Feedback
1. Strong Revenue Growth and Strategic Acquisitions in 2024 and Early 2025.
Pennant Group reported robust financial performance in 2024, with total revenue increasing by 27.6% over the previous year, reaching $695.2 million. This growth was further supported by strategic acquisitions in both its senior living and home health and hospice segments. In early 2025, the company closed on three senior living transactions and added five home health agencies and four hospice agencies, expanding its operational footprint across multiple states. These newly acquired properties were noted to be performing "above initial expectations".
2. Positive 2025 Financial Guidance and Growth Projections.
The company provided optimistic guidance for the full year 2025, projecting total revenue between $800.0 million and $865.0 million and adjusted earnings per diluted share ranging from $1.03 to $1.11. This forecast indicates significant anticipated growth, with the midpoint representing a 13.8% increase in adjusted earnings per share over 2024 results and a substantial 46.6% growth over 2023.
Show more
Stock Movement Drivers
Fundamental Drivers
The 19.8% change in PNTG stock from 9/22/2025 to 12/22/2025 was primarily driven by a 20.6% change in the company's P/E Multiple.| 9222025 | 12222025 | Change | |
|---|---|---|---|
| Stock Price ($) | 24.58 | 29.45 | 19.81% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 798.92 | 847.27 | 6.05% |
| Net Income Margin (%) | 3.36% | 3.15% | -6.14% |
| P/E Multiple | 31.64 | 38.17 | 20.62% |
| Shares Outstanding (Mil) | 34.53 | 34.60 | -0.21% |
| Cumulative Contribution | 19.81% |
Market Drivers
9/22/2025 to 12/22/2025| Return | Correlation | |
|---|---|---|
| PNTG | 19.8% | |
| Market (SPY) | 2.7% | 20.2% |
| Sector (XLV) | 13.7% | 29.2% |
Fundamental Drivers
The 4.4% change in PNTG stock from 6/23/2025 to 12/22/2025 was primarily driven by a 13.2% change in the company's Total Revenues ($ Mil).| 6232025 | 12222025 | Change | |
|---|---|---|---|
| Stock Price ($) | 28.22 | 29.45 | 4.36% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 748.17 | 847.27 | 13.25% |
| Net Income Margin (%) | 3.40% | 3.15% | -7.28% |
| P/E Multiple | 38.26 | 38.17 | -0.24% |
| Shares Outstanding (Mil) | 34.47 | 34.60 | -0.37% |
| Cumulative Contribution | 4.36% |
Market Drivers
6/23/2025 to 12/22/2025| Return | Correlation | |
|---|---|---|
| PNTG | 4.4% | |
| Market (SPY) | 14.4% | 22.6% |
| Sector (XLV) | 18.0% | 19.5% |
Fundamental Drivers
The 7.6% change in PNTG stock from 12/22/2024 to 12/22/2025 was primarily driven by a 29.9% change in the company's Total Revenues ($ Mil).| 12222024 | 12222025 | Change | |
|---|---|---|---|
| Stock Price ($) | 27.38 | 29.45 | 7.56% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 652.30 | 847.27 | 29.89% |
| Net Income Margin (%) | 3.24% | 3.15% | -2.81% |
| P/E Multiple | 39.20 | 38.17 | -2.64% |
| Shares Outstanding (Mil) | 30.28 | 34.60 | -14.26% |
| Cumulative Contribution | 5.37% |
Market Drivers
12/22/2024 to 12/22/2025| Return | Correlation | |
|---|---|---|
| PNTG | 7.6% | |
| Market (SPY) | 16.9% | 28.4% |
| Sector (XLV) | 14.5% | 27.2% |
Fundamental Drivers
The 196.0% change in PNTG stock from 12/23/2022 to 12/22/2025 was primarily driven by a 1322.2% change in the company's Net Income Margin (%).| 12232022 | 12222025 | Change | |
|---|---|---|---|
| Stock Price ($) | 9.95 | 29.45 | 195.98% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 460.34 | 847.27 | 84.05% |
| Net Income Margin (%) | 0.22% | 3.15% | 1322.17% |
| P/E Multiple | 286.16 | 38.17 | -86.66% |
| Shares Outstanding (Mil) | 29.34 | 34.60 | -17.95% |
| Cumulative Contribution | 186.45% |
Market Drivers
12/23/2023 to 12/22/2025| Return | Correlation | |
|---|---|---|
| PNTG | 108.3% | |
| Market (SPY) | 47.7% | 32.5% |
| Sector (XLV) | 18.4% | 26.5% |
Price Returns Compared
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| PNTG Return | 76% | -60% | -52% | 27% | 91% | 11% | -11% |
| Peers Return | � | � | � | 24% | 1% | 29% | � |
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 17% | 113% |
Monthly Win Rates [3] | |||||||
| PNTG Win Rate | 75% | 17% | 50% | 50% | 67% | 67% | |
| Peers Win Rate | � | � | 42% | 55% | 52% | 60% | |
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 73% | |
Max Drawdowns [4] | |||||||
| PNTG Max Drawdown | -69% | -67% | -60% | -6% | 0% | -17% | |
| Peers Max Drawdown | � | � | � | -18% | -13% | -17% | |
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: ENSG, ADUS, BKD, CHE, EHAB.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/22/2025 (YTD)
How Low Can It Go
| Event | PNTG | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -86.3% | -25.4% |
| % Gain to Breakeven | 628.1% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -69.4% | -33.9% |
| % Gain to Breakeven | 226.5% | 51.3% |
| Time to Breakeven | 147 days | 148 days |
Compare to ACHC, AMTU, MCTA, PARK, HCA
In The Past
Pennant's stock fell -86.3% during the 2022 Inflation Shock from a high on 1/6/2021. A -86.3% loss requires a 628.1% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth over time.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
AI Analysis | Feedback
- It's like **HCA Healthcare**, but focused on skilled nursing and senior living facilities instead of hospitals.
- The **Marriott** or **Hilton** of skilled nursing and senior living communities.
AI Analysis | Feedback
- Senior Living Services: Pennant operates senior living communities providing residential care, assisted living, and memory care services to seniors.
- Home Health Services: The company offers skilled nursing, physical, occupational, and speech therapy, and other medical services in the comfort of patients' homes.
- Hospice Services: Pennant provides compassionate end-of-life care, pain management, and emotional and spiritual support to terminally ill patients and their families.
AI Analysis | Feedback
Pennant (PNTG)
Pennant (PNTG) primarily serves individuals through its network of senior living communities and skilled nursing facilities. Its major customers can be categorized as follows:
- Senior Living Residents: These individuals seek a residential environment that provides support for daily living. This category includes residents in independent living, assisted living, and memory care communities who require varying levels of assistance with activities of daily living (ADLs) or specialized care for cognitive impairments.
- Skilled Nursing Facility Patients: These individuals require post-acute medical care, rehabilitation services, or long-term skilled nursing care. They typically transition to Pennant's facilities after a hospital stay, surgery, or due to chronic health conditions requiring continuous medical supervision and therapeutic services.
AI Analysis | Feedback
null
AI Analysis | Feedback
Brent Guerisoli Chief Executive Officer
Mr. Guerisoli has served as the Chief Executive Officer of The Pennant Group, Inc. since August 1, 2022, and as Chairman of the Board since January 1, 2025. He was previously the President of Pennant from January 2020. Since joining Pennant in 2012, Mr. Guerisoli has directed growth initiatives across several states and contributed significantly to leadership recruiting, development, and training within the organization. He also led a turnaround in the company's senior living sector. Before becoming President of Pennant, he served as President of Cornerstone, a Pennant subsidiary, starting in 2018. Pennant Group was spun off from The Ensign Group (NASDAQ: ENSG) in 2019.
Lynette Walbom Chief Financial Officer
Ms. Walbom was appointed Chief Financial Officer of The Pennant Group, Inc. effective May 22, 2023. Prior to joining Pennant, she was the vice president of financial reporting and tax for Raising Cane's Restaurants, LLC, where her responsibilities included overseeing acquisitions, accounting systems, and equity management. Before her tenure at Raising Cane's, Ms. Walbom held the position of CFO for a family office investment firm. This firm backed several companies across various industries, including financial services, computer services, real estate development, and franchising.
John J. Gochnour President and Chief Operating Officer
Mr. Gochnour serves as the President and Chief Operating Officer of The Pennant Group, Inc. He was previously the Chief Operating Officer.
Kirk Cheney Executive Vice President
Mr. Cheney holds the title of Executive Vice President at The Pennant Group, Inc. He is also listed as the Executive Vice President, General Counsel, and Corporate Secretary.
Jason Steik Chief Clinical Officer
Mr. Steik is the Chief Clinical Officer for The Pennant Group, Inc.
AI Analysis | Feedback
The Pennant Group (PNTG) faces several key risks, primarily stemming from the highly regulated and litigious nature of the healthcare industry, along with challenges in human capital management.- Regulatory and Reimbursement Uncertainty: As a provider of home health, hospice, and senior living services, Pennant Group is heavily reliant on government programs like Medicare and Medicaid for a significant portion of its revenue. Fluctuations in Medicare and Medicaid payment rates, or changes in the rules governing these programs, can directly impact the company's margins and overall financial performance. Compliance with a complex web of federal and state regulations, including those related to fair housing, fire, and safety, may necessitate unanticipated and costly expenditures. Regulatory and reimbursement risks are consistently identified as a primary concern, threatening the company's earnings and operational stability.
- Litigation and Professional Liability Claims: The nature of Pennant Group's services, which involve the care of elderly and often vulnerable patients, inherently carries a significant risk of liability. The company is subject to litigation, including professional liability claims alleging personal injury, which could result in substantial legal costs, large settlement amounts, or damage awards. The healthcare industry has seen an increase in the frequency and severity of such litigation, including class action lawsuits for employee-related claims like wrongful discharge or wage and hour disputes.
- Ability to Attract and Retain Key Personnel: Pennant Group operates with a decentralized model, emphasizing strong local leadership within its independent operating subsidiaries. The company's success is highly dependent on its ability to attract and retain key personnel, particularly top CEOs and Chief Clinical Officers, who are often sought after by competitors. A failure to secure and retain these crucial individuals could adversely affect the company's business, financial position, and results of operations.
AI Analysis | Feedback
The rise of highly integrated digital health platforms leveraging artificial intelligence, remote patient monitoring, and advanced virtual care capabilities. These platforms are creating alternative, more efficient, and potentially more preferred models for senior care and home health services, directly challenging traditional, labor-intensive facility-based and in-person home health service delivery. This emerging trend can reduce the demand for traditional facility beds and frequent in-person home health visits by enabling effective care delivery with lower reliance on physical infrastructure and traditional staffing ratios, thereby eroding market share and profitability for conventional providers like Pennant.
AI Analysis | Feedback
The Pennant Group (PNTG) primarily operates in three addressable markets within the United States: home health, hospice care, and senior living services.
Home Health Services
The addressable market for home health services in the U.S. was estimated at approximately $162.35 billion in 2024. This market is projected to grow to approximately $381.40 billion by 2033, with a compound annual growth rate (CAGR) of 10.00% from 2025 to 2033. Other estimates suggest the U.S. home healthcare market size was around $194.24 billion in 2024, expected to reach $222.61 billion by 2025, and projected to be worth approximately $644.37 billion by 2034, at a CAGR of 12.74% from 2025 to 2034.
Hospice Care Services
The U.S. hospice market was valued at approximately $29.92 billion in 2024. This market is projected to reach about $39.09 billion by 2030, growing at a CAGR of 4.61% from 2025 to 2030. Another estimate for the U.S. hospice market size in 2024 was $30.25 billion, with a projection to reach around $47.52 billion by 2034 at a CAGR of 4.62% from 2025 to 2034. The market size for Hospices & Palliative Care Centers in the U.S. is estimated at $39.0 billion in 2025.
Senior Living Services
The addressable market for senior living services in the U.S. exhibits a range of estimates. One source estimated the U.S. senior living market size at $907.59 billion in 2024, with an expectation to reach $1.33 trillion by 2033, growing at a CAGR of 4.42% from 2025 to 2033. Another report valued the U.S. senior living market at $923.20 billion in 2023, projecting growth to approximately $1.22 trillion by 2030 at a CAGR of 4.16%. Other estimates place the U.S. senior living market at around $111.20 billion in 2024, with a projection to reach approximately $201.03 billion by 2034 at a CAGR of 6.10% between 2025 and 2034. Pennant's offerings in this segment include residential accommodations, activities, meals, housekeeping, and assistance with daily living for independent seniors or those requiring some support.
AI Analysis | Feedback
Here are 3-5 expected drivers of future revenue growth for Pennant (PNTG) over the next 2-3 years:
- Acquisitions and Strategic Expansion: Pennant consistently pursues strategic acquisitions to expand its market presence and operational capabilities. A significant recent example is the acquisition of 54 operations from UnitedHealth Group and Amedisys in October 2025, which is expected to serve as a platform for growth in the Southeastern United States. The company continues to evaluate additional acquisition opportunities.
- Organic Growth in Home Health and Hospice Services: The Home Health and Hospice segment is a primary revenue driver, accounting for a substantial portion of Pennant's total revenue. Future growth is anticipated through increased patient admissions and a rising average daily census within these services.
- Occupancy Growth and Pricing in Senior Living Services: Revenue growth in the Senior Living segment is expected to be fueled by incremental occupancy gains in its communities and an increase in the average monthly revenue per occupied room.
- Demographic Tailwinds: The increasing senior population in the United States acts as a significant demographic tailwind, supporting organic growth and driving higher utilization rates across Pennant's senior care segments.
- Operational Efficiencies and Margin Expansion: While primarily impacting profitability, improved operational efficiencies resulting from the scaling of operations and investments in technology are expected to contribute to higher profit margins. This enhanced efficiency and profitability can support sustained revenue growth and provide capital for further expansion.
AI Analysis | Feedback
Share Repurchases
- On December 13, 2022, The Pennant Group announced a share repurchase program authorized to repurchase common stock, which expired on December 12, 2023.
- This program was intended to allow opportunistic investment in the company's stock when it was undervalued.
- As of September 30, 2025, and December 31, 2024, treasury stock at cost remained at $65,000, representing 3 shares.
Share Issuance
- The Pennant Group has diluted its shareholders, with the share count increasing by 16.6% over a five-year period.
- The issuance of common stock from the exercise of options resulted in $909,000 for the nine months ended September 30, 2025, and $2,019,000 for the nine months ended September 30, 2024.
- A Q1 2025 equity offering positively impacted the company's financial performance.
Outbound Investments
- Pennant has made a total of 14 acquisitions, with significant activity in 2020 (4 acquisitions), 2023 (3 acquisitions), and 2025 (2 acquisitions as of September).
- On October 1, 2025, Pennant completed the acquisition of 54 home health, hospice, and personal care operations from UnitedHealth Group and Amedisys for $146.5 million, primarily in Tennessee, Alabama, and Georgia.
- In November 2025, Pennant acquired operations and real property for a 55-bed assisted living community in Lewiston, Idaho (Twin Rivers Senior Living) and completed the purchase of real property for Honey Creek Heights Senior Living in West Allis, Wisconsin, adding 135 beds.
Capital Expenditures
- Net cash used in investing activities, which includes capital expenditures and acquisitions, was $(74,950) thousand for the nine months ended September 30, 2025, and $(66,287) thousand for the nine months ended September 30, 2024.
- Capital expenditures reflected in accounts payable and accrued liabilities amounted to $1,076,000 for the nine months ended September 30, 2025, and $1,630,000 for the nine months ended September 30, 2024.
- The primary focus of capital allocation, including capital expenditures, is to drive organic growth and acquire additional home health, hospice, and senior living operations in existing and new markets.
Latest Trefis Analyses
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select ideas related to PNTG. For more, see Trefis Trade Ideas.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11142025 | CRL | Charles River Laboratories International | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 21.0% | 21.0% | -3.7% |
| 11142025 | GDRX | GoodRx | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | -8.8% | -8.8% | -11.8% |
| 11142025 | ASTH | Astrana Health | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 11.5% | 11.5% | -5.5% |
| 11142025 | SGRY | Surgery Partners | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 2.7% | 2.7% | -1.4% |
| 11072025 | TFX | Teleflex | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 13.8% | 13.8% | -5.1% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for Pennant
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 70.73 |
| Mkt Cap | 2.3 |
| Rev LTM | 1,939 |
| Op Inc LTM | 94 |
| FCF LTM | 54 |
| FCF 3Y Avg | 79 |
| CFO LTM | 166 |
| CFO 3Y Avg | 135 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 12.0% |
| Rev Chg 3Y Avg | 9.7% |
| Rev Chg Q | 11.9% |
| QoQ Delta Rev Chg LTM | 2.8% |
| Op Mgn LTM | 7.1% |
| Op Mgn 3Y Avg | 6.5% |
| QoQ Delta Op Mgn LTM | -0.1% |
| CFO/Rev LTM | 7.4% |
| CFO/Rev 3Y Avg | 7.3% |
| FCF/Rev LTM | 4.9% |
| FCF/Rev 3Y Avg | 4.2% |
Price Behavior
| Market Price | $29.45 | |
| Market Cap ($ Bil) | 1.0 | |
| First Trading Date | 10/01/2019 | |
| Distance from 52W High | -2.5% | |
| 50 Days | 200 Days | |
| DMA Price | $26.53 | $25.90 |
| DMA Trend | up | up |
| Distance from DMA | 11.0% | 13.7% |
| 3M | 1YR | |
| Volatility | 32.9% | 37.8% |
| Downside Capture | 28.50 | 68.07 |
| Upside Capture | 112.71 | 64.64 |
| Correlation (SPY) | 21.0% | 28.2% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 0.45 | 0.54 | 0.63 | 0.87 | 0.57 | 0.76 |
| Up Beta | -1.88 | -0.94 | -0.53 | 1.25 | 0.53 | 0.51 |
| Down Beta | 1.27 | 1.14 | 0.89 | 0.51 | 0.39 | 0.64 |
| Up Capture | 191% | 98% | 111% | 61% | 48% | 125% |
| Bmk +ve Days | 13 | 26 | 39 | 74 | 142 | 427 |
| Stock +ve Days | 13 | 25 | 35 | 62 | 126 | 402 |
| Down Capture | 36% | 47% | 61% | 115% | 89% | 97% |
| Bmk -ve Days | 7 | 16 | 24 | 52 | 107 | 323 |
| Stock -ve Days | 7 | 17 | 28 | 63 | 118 | 339 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Comparison of PNTG With Other Asset Classes (Last 1Y) | |||||||
|---|---|---|---|---|---|---|---|
| PNTG | Sector ETF | Equity | Gold | Commodities | Real Estate | Bitcoin | |
| Annualized Return | 0.8% | 13.6% | 14.7% | 67.3% | 6.8% | -0.5% | -16.6% |
| Annualized Volatility | 37.8% | 17.3% | 19.7% | 19.3% | 15.2% | 17.6% | 35.4% |
| Sharpe Ratio | 0.10 | 0.57 | 0.57 | 2.54 | 0.23 | -0.18 | -0.25 |
| Correlation With Other Assets | 27.6% | 29.2% | -2.8% | 4.5% | 30.9% | 16.7% | |
ETFs used for asset classes: Sector ETF = XLV, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Comparison of PNTG With Other Asset Classes (Last 5Y) | |||||||
|---|---|---|---|---|---|---|---|
| PNTG | Sector ETF | Equity | Gold | Commodities | Real Estate | Bitcoin | |
| Annualized Return | -12.0% | 8.7% | 15.0% | 18.9% | 11.8% | 5.1% | 35.8% |
| Annualized Volatility | 52.9% | 14.5% | 17.1% | 15.5% | 18.7% | 18.9% | 48.9% |
| Sharpe Ratio | -0.04 | 0.42 | 0.71 | 0.98 | 0.51 | 0.18 | 0.63 |
| Correlation With Other Assets | 26.9% | 34.4% | 5.5% | 7.5% | 32.5% | 15.3% | |
ETFs used for asset classes: Sector ETF = XLV, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Comparison of PNTG With Other Asset Classes (Last 10Y) | |||||||
|---|---|---|---|---|---|---|---|
| PNTG | Sector ETF | Equity | Gold | Commodities | Real Estate | Bitcoin | |
| Annualized Return | 11.4% | 10.0% | 14.9% | 14.9% | 6.7% | 5.5% | 69.9% |
| Annualized Volatility | 64.0% | 16.7% | 18.0% | 14.8% | 17.6% | 20.8% | 55.8% |
| Sharpe Ratio | 0.44 | 0.50 | 0.71 | 0.84 | 0.30 | 0.23 | 0.90 |
| Correlation With Other Assets | 33.0% | 40.3% | 9.1% | 17.9% | 40.3% | 18.8% | |
ETFs used for asset classes: Sector ETF = XLV, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 11/5/2025 | -5.6% | 0.3% | 14.5% |
| 8/6/2025 | 8.4% | 17.2% | 9.1% |
| 2/27/2025 | -10.8% | -9.6% | -3.6% |
| 11/6/2024 | -3.4% | -1.0% | -9.7% |
| 8/6/2024 | -1.9% | 7.4% | 15.8% |
| 2/28/2024 | 10.5% | 12.0% | 16.3% |
| 11/7/2023 | 8.1% | 11.6% | 14.1% |
| 8/8/2023 | -2.1% | 5.9% | 0.3% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 8 | 11 | 13 |
| # Negative | 13 | 10 | 8 |
| Median Positive | 10.6% | 12.0% | 14.5% |
| Median Negative | -6.9% | -14.0% | -14.9% |
| Max Positive | 40.7% | 49.8% | 41.8% |
| Max Negative | -23.3% | -34.9% | -49.1% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 9302025 | 11052025 | 10-Q 9/30/2025 |
| 6302025 | 8062025 | 10-Q 6/30/2025 |
| 3312025 | 5062025 | 10-Q 3/31/2025 |
| 12312024 | 2272025 | 10-K 12/31/2024 |
| 9302024 | 11062024 | 10-Q 9/30/2024 |
| 6302024 | 8062024 | 10-Q 6/30/2024 |
| 3312024 | 5062024 | 10-Q 3/31/2024 |
| 12312023 | 2282024 | 10-K 12/31/2023 |
| 9302023 | 11072023 | 10-Q 9/30/2023 |
| 6302023 | 8082023 | 10-Q 6/30/2023 |
| 3312023 | 5042023 | 10-Q 3/31/2023 |
| 12312022 | 2232023 | 10-K 12/31/2022 |
| 9302022 | 11072022 | 10-Q 9/30/2022 |
| 6302022 | 8082022 | 10-Q 6/30/2022 |
| 3312022 | 5092022 | 10-Q 3/31/2022 |
| 12312021 | 2282022 | 10-K 12/31/2021 |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.